Vitamin D Therapy Market to grow with a CAGR of 3.00%
Increasing
healthcare infrastructure and initiatives taken by the government are the major
drivers for the Global Vitamin D Therapy Market.
According
to TechSci Research report, “Global Vitamin D Therapy Market Industry Size,
Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Vitamin D Therapy
Market has valued at USD 2.50 billion in 2022 and is anticipated to witness an
impressive growth in the forecast period with a CAGR of 3.00 % through 2028. This
can be ascribed to collaborations and partnerships among leading companies with
a diverse approach to merge the expertise of individual companies and to
strengthen their position in the market.
Preventive
healthcare is a significant driver behind the demand for Vitamin D therapy in
the global market. Preventive healthcare involves taking proactive measures to
maintain and improve health, prevent diseases, and reduce the risk of health
problems. Increasing awareness of the importance of Vitamin D for overall
health and well-being has led individuals to seek preventive measures to
maintain optimal Vitamin D levels. Vitamin D is crucial for calcium absorption,
which is essential for strong bones. Many individuals, especially older adults,
use Vitamin D therapy as a preventive measure to reduce the risk of
osteoporosis and fractures. Vitamin D is linked to immune system function.
Preventive healthcare strategies often include Vitamin D supplementation to
support the immune system, especially during flu seasons or when facing immune
challenges. Healthcare providers play a crucial role in patient education. They
may recommend Vitamin D therapy as part of preventive healthcare plans,
emphasizing its benefits for specific health goals. As people aim for healthier
aging and maintaining an active lifestyle as they grow older, Vitamin D therapy
can support muscle strength and function, contributing to overall mobility and
quality of life. Preventive healthcare is part of a broader wellness approach,
where individuals actively seek to optimize their health and well-being.
Vitamin D therapy aligns with this wellness philosophy.
Vitamin
D belongs to a group of fat-soluble secosteroids found in select foods and is
vital for the absorption of calcium, phosphate, and magnesium in the
intestines. When the skin is exposed to sunlight, it triggers the production of
vitamin D from cholesterol. Insufficient vitamin D can result from limited sun
exposure, absorption issues, inactive lifestyles, or enhanced breakdown due to
specific medications. This deficiency can lead to muscle weakness and bone
discomfort, making Vitamin D therapy a common approach in various bone-related
conditions.
In March 2021, Royal DSM, a purpose-driven global
science-based company specializing in nutrition, health, and sustainable
living, has introduced ampli-D, a rapidly acting form of vitamin D designed for
dietary supplements in the Australian market. ampli-D offers Australian
consumers a quicker and more efficient means of elevating their vitamin D
levels in the body, achieving this in just days and weeks rather than the usual
months. This rapid boost is aimed at supporting immune health. Vitamin D, often
referred to as the "sunshine vitamin," is well-known for its role in
promoting bone and muscle health. Its increasingly recognized function in
bolstering a healthy immune system is crucial. Despite its vital role in
overall health and well-being, vitamin D deficiency is a widespread global
health concern, affecting more than 80% of the world's population.
Sustainability and sourcing can present challenges in
the global Vitamin D therapy market. The primary source of Vitamin D3
(cholecalciferol) is lanolin from sheep's wool, while Vitamin D2
(ergocalciferol) can be derived from yeast or plant sources. The challenge lies
in ensuring that these ingredients are sustainably sourced and produced without
causing harm to animals or the environment. The extraction of lanolin from
sheep's wool raises animal welfare concerns. Ethical sourcing practices and
certifications, such as cruelty-free or sustainable farming methods, are
increasingly important to consumers. Unsustainable practices in lanolin
production or yeast cultivation can have negative environmental impacts, such
as deforestation or excessive water use. Sustainable sourcing practices aim to
minimize these effects.
Consumers are becoming more conscious of product
sourcing and production methods. They often seek transparency in labelling and
expect companies to provide information about the origins of Vitamin D
ingredients.
Browse
over XX market data Figures and spread through XX Pages and an in-depth TOC on
"Vitamin D Therapy Market.”
Global Vitamin D Therapy Market segmentation is
based on Route of Administration, Purchase Pattern, Purchase Pattern, By
Company, and Region.
Based on Application, Global Vitamin D Therapy
Market is segmented into Osteoporosis, Rickets, Skin Diseases, Muscle Weakness,
Autoimmune Disorders.
Muscle weakness is a condition characterized by a decreased ability of muscles
to generate force and perform tasks that would normally be within their
capacity. It can affect a specific muscle or group of muscles, or it may
involve widespread weakness throughout the body. Muscle weakness can be
temporary or chronic and can range from mild to severe. Some medications, such
as certain muscle relaxants or statins, may lead to muscle weakness as a side
effect. Identifying the underlying cause of muscle weakness is essential for
effective treatment. Healthcare providers may use a combination of physical
examinations, medical history assessments, blood tests, imaging studies, and
nerve conduction tests to diagnose the condition. The treatment of muscle
weakness depends on its underlying cause.
Based on Region, the North America segment is the dominating
segment of Global Vitamin D Therapy Market. North
America's advanced healthcare infrastructure, including a well-established
pharmaceutical industry, allowed for the easy production, distribution, and
marketing of Vitamin D supplements and therapies. The culture of wellness and
health-focused lifestyles was prevalent in North America, leading to a greater
demand for supplements and therapies that were perceived to support overall
health and well-being. North American pharmaceutical and healthcare companies
invested significantly in research and development, leading to the introduction
of innovative Vitamin D products and formulations. The regulatory environment
in North America was relatively well-defined, providing a level of trust and
assurance to consumers regarding the quality and safety of Vitamin D products. Robust
marketing efforts by both pharmaceutical companies and healthcare professionals
contributed to the widespread use of Vitamin D therapy in North America. Easy
access to healthcare professionals and over-the-counter supplements in
pharmacies and retail stores made it convenient for consumers to obtain Vitamin
D therapy.
Asia
Pacific is the fastest-growing region in the Global Vitamin D Therapy Market. Increased
awareness of the importance of Vitamin D for overall health and well-being has
led to higher demand for Vitamin D supplements in Asia Pacific. Consumers have
become more health-conscious and are actively seeking ways to address potential
deficiencies. Urbanization and changing lifestyles in many Asia Pacific
countries have led to reduced sun exposure due to indoor work environments and
a shift toward more sedentary lifestyles. This has increased the risk of
Vitamin D deficiency, driving the demand for supplementation. Several countries
in Asia Pacific have rapidly aging populations. Older individuals are more
susceptible to Vitamin D deficiency and related health issues, such as
osteoporosis and fractures, which has driven the demand for Vitamin D therapy.
Improved access to healthcare services and growing healthcare infrastructure in
many Asia Pacific countries have facilitated Vitamin D testing and
supplementation recommendations by healthcare providers.
Some
of the major companies operating in the Global
Vitamin D Therapy Market include:
- Ortho
Molecular Products Inc.
- Biotics
Research Corporation
- GlaxoSmithKline
PLC
- Abbott
Laboratories
- Pfizer
Inc.
- Novartis
AG
- Merck
& Co Inc.
- Cadila
Healthcare Ltd.
- Alkem
Laboratories Ltd
- Torrent
Pharmaceuticals Ltd.
Download Free Sample Report
Customers can also request 10% free
customization on this report.
“Certain areas, particularly in North
America, are projected to exert significant demand of Vitamin D Therapy. The
growth in the competitive landscape and the presence of well-established
companies in the market, committed to enhance the overall wellbeing of people each
year, are expected to contribute to a remarkable growth of the Global Vitamin D
Therapy Market in the forecast period," said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based Global management consulting
firm.
Vitamin D
Therapy by Route of Administration (Oral, Parenteral), By Purchase Pattern (OTC
Drugs, Prescription Drugs), By Application (Osteoporosis, Rickets, Skin
Diseases, Muscle Weakness, Autoimmune Disorders), By Region, and Competition by
Region, By Competition Forecast
& Opportunities, 2018-2028F has
evaluated the future growth potential of Global Vitamin D Therapy Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide innovative market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Vitamin D Therapy Market.
Contact
Mr.
Ken Mathews
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States-
10170
Tel:
+13322586602
Email: [email protected]
Website: www.techsciresearch.com